These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
3. Medium-term outcome of tacrolimus immunosuppression following rejection or graft dysfunction in heart transplant patients. Marcus N, Khaghani A, Burke M, Yacoub M, Banner N. Transplant Proc; 1998 Jun; 30(4):1134-5. PubMed ID: 9636460 [No Abstract] [Full Text] [Related]
4. Long-term outcome with the use of OKT3 induction therapy in heart transplant patients: a single-center experience. Adamson R, Obispo E, Dychter S, Dembitsky W, Moreno-Cabral R, Jaski B, Gordon J, Hoagland P, Moore K, King J, Andrews J, Rich M, Daily PO. Transplant Proc; 1998 Jun; 30(4):1107-9. PubMed ID: 9636449 [No Abstract] [Full Text] [Related]
5. Excellent long-term survival of low-risk, first renal allografts using cyclosporine/azathioprine double therapy. Faull RJ, Bannister KM, Russ GR, Mathew TH, Clarkson AR. Transplant Proc; 1999 Jun; 31(1-2):1155-6. PubMed ID: 10083516 [No Abstract] [Full Text] [Related]
18. Efficacy and safety of tacrolimus versus cyclosporine in kidney and pancreas transplant recipients. el-Ghoroury M, Hariharan S, Peddi VR, Munda R, Schroeder TJ, Demmy AM, Alexander JW, First MR. Transplant Proc; 1997 Jun; 29(1-2):649-51. PubMed ID: 9123461 [No Abstract] [Full Text] [Related]
19. Acute cardiac ongoing rejection: comparison between different strategies. Forni A, Faggian G, Luciani GB, Lamascese N, Mazzucco A. Transplant Proc; 2001 May; 33(3):2395-7. PubMed ID: 11377573 [No Abstract] [Full Text] [Related]